Archive for the ‘wiley retractions’ Category
Back in December, the University of Kansas issued a public censure of a former water researcher who, the school says, engaged in a pattern of plagiarism and other shoddy publishing practices.
Marios Sophocleous, who’d held the position of senior scientist at the Kansas Geological Survey:
In December, a group of biologists in Thailand published a paper in the Nordic Journal of Botany heralding the discovery of a new species of plant:
Bauhinia saksuwaniae, a new species from northeastern Thailand is described and illustrated. It appears to be an endemic and endangered species. The new species is obviously distinct from all other species of Thai Bauhinia in having large orbicular persistent bracteoles forming a cup-shape and enclosing a young floral bud.
Almost two years ago, we brought you — with the help of Trevor Stokes — the story of a stem cell researcher in Korea whose publication record, and career, unraveled after evidence of image manipulation surfaced in her work.
We’ve reported on four retractions, all in Antioxidants & Redox Signaling, by Soo-Kyung Kang, formerly of Seoul National University resulting from the efforts of a whistleblower. There has been another in Human Gene Therapy: Read the rest of this entry »
Ulrich Lichtenthaler, the management professor who has had 13 papers retracted, has a correction in the Journal of Product Innovation Management.
In a case whose irony is not lost on those involved, an article about publishing ethics has been retracted because one of the authors re-used material he’d written for an earlier piece. But the authors and the journal’s editors have turned the episode into a learning opportunity.
Alas, an Idaho anthropologist failed to heed that lesson when she published “Joined at the hip? A paleoepidemiological study of developmental dysplasia of the hip and its relation to swaddling practices among indigenous peoples of North America,” in the American Journal of Human Biology last October.
A group of researchers from MD Anderson Cancer Center in Houston has lost a 2013 paper in BJU International for running afoul of their institution’s ethics review board, and of military reviewers, as well.
The paper, “Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance,” looked at prostate cancer screening in men 55 and under — considered young for the older-man’s disease. According to the abstract: Read the rest of this entry »